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Abstract
Background: The NIMA-related kinases (Neks) are widespread among eukaryotes. In mammalians they represent
an evolutionarily conserved family of 11 serine/threonine kinases, with 40-45% amino acid sequence identity to the
Aspergillus nidulans mitotic regulator NIMA within their catalytic domains. Neks have cell cycle-related functions and
were recently described as related to pathologies, particularly cancer, consisting in potential chemotherapeutic
targets. Human Nek6, -7 and -9 are involved in the control of mitotic spindle formation, acting together in a
mitotic kinase cascade, but their mechanism of regulation remain elusive.
Results: In this study we performed a biophysical and structural characterization of human Nek6 with the aim of
obtaining its low resolution and homology models. SAXS experiments showed that hNek6 is a monomer of a
mostly globular, though slightly elongated shape. Comparative molecular modeling together with disorder
prediction analysis also revealed a flexible disordered N-terminal domain for hNek6, which we found to be
important to mediate interactions with diverse partners. SEC-MALS experiments showed that hNek6 conformation
is dependent on its activation/phosphorylation status, a higher phosphorylation degree corresponding to a bigger
Stokes radius. Circular dichroism spectroscopy confirmed our in silico predictions of secondary structure content
and thermal stability shift assays revealed a slightly higher stability of wild-type hNek6 compared to the activation
loop mutant hNek6(S206A).
Conclusions: Our data present the first low resolution 3D structure of hNek6 protein in solution. SAXS,
comparative modeling and SEC-MALS analysis revealed that hNek6 is a monomeric kinase of slightly elongated
shape and a short unfolded N-terminal domain.
Background
Mitotic progression and assembly of the bipolar mitotic
spindle are regulated by several serine/threonine protein
kinases, including members of the cyclin-dependent kinase
(Cdk), Polo-like kinase (Plk), Aurora, and NIMA-related
kinase (Nek) families [1-4]. The founding member of Nek
family, the NIMA kinase of Aspergillus nidulans,c o n t r i -
butes to multiple aspects of mitotic progression including
the timing of mitotic entry, chromatin condensation, spin-
dle organization and cytokinesis. Mammals contain a large
family of eleven Neks, the catalytic domain of which is
evolutionarily related to that of NIMA [4]. Nek2 has a cen-
tral role in centrosome maturation and disjunction [5],
whereas Nek1 and Nek8 have been proposed to contribute
to ciliary function [6,7]. Besides Nek2, Nek1, -6, -7 and -9
were also described to participate in centrosomal regula-
tion [7-11]. Nek6, Nek7 [9] and Nek9 [12] are involved in
the control of mitotic spindle formation, acting together in
a mitotic kinase cascade, with Nek9 being upstream of
Nek6 and Nek7 [13]. Nek kinases are also described as
related to pathologies, particularly cancer, presenting
thereby interesting potential chemotherapeutic targets
[14-20]. Recently, hNek6 was described to have its tran-
script, protein, and/or kinase activity levels highly elevated
in a number of tumors and human cancer cell lines, indi-
cating an important role for hNek6 in tumorigenesis
[21-24].
Structurally, Neks in general are characterized by hav-
ing a conserved N-terminal catalytic domain, followed
by a nonconserved C-terminal regulatory domain that
varies in size and structure. However, Nek6 and Nek7
are significant exceptions to this, in that they are the
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domain with a relatively short N-terminal extension [4].
Although they share significant similarity with each
other, being ~86% identical within their catalytic
domains, the N-terminal extensions are not conserved,
and it has been suggested that they may play a role in
differential regulation of the kinases [25].
The mechanisms of regulation of hNek6, -7, and -9
kinases are currently unknown, and elucidating this
pathway would provide relevant knowledge on early
mitotic events as well as new hints for drug design and
cancer therapy. However, hNek2 and hNek7 are the
only NIMA-related kinases for which structures have
been reported [26-28]. In this context, we present here
the first low resolution three-dimensional structure of
hNek6 protein in solution. SAXS experiments, together
with SEC-MALS and comparative molecular modeling
revealed a monomeric mostly globular, though slightly
elongated conformation for hNek6, with a flexible disor-
dered N-terminal domain.
Results and Discussion
Human Nek6 is predicted to be phosphorylated at
various sites and has an unfolded short N-terminal
domain
Human Nek6 amino acid sequence was analyzed consid-
ering its secondary structure, disordered regions, con-
served motifs and putative phosphorylation sites by
upstream kinases, resulting in a linear representation of
its main structure predictions (Figure 1A). These ana-
lyses were also performed for hNek7, for which the crys-
tallographic structure was recently determined [28], in
order to validate our results (Figure 1B).
Our consensus of secondary structure was scored by
the number of times (one to five times) the predicted
secondary structure element (a-helices, b-strands or
coils) scored positive from five predictions using differ-
ent databases: PredictProtein/Prof [29], PSIPRED [30],
SSpro [31], SOPMA [32] and GOR4 [33]. In summary,
the secondary structure analysis suggested that hNek6
was composed of approximately 34% a-helices, 12% b-
strands and 54% coils. Our hNek7 consensus of pre-
dicted secondary structure is 80% identical to the
author-approved secondary structure in PDB (2WQM)
(Figure 1B).
In the case of the disordered regions predictions, our
consensus was obtained following the same criteria as
for the secondary structure predictions, except that we
used here nine different databases: FoldIndex [34],
GlobPlot Russell/Linding [35], PONDR VL-XT [36],
DISpro [37], IUPred [38], DisEMBL Hot-loops, Dis-
EMBL Remark-465, DisEMBL Loops/coils [39], and
VSL2B [40]. From this analysis, we were able to identify
a short high scored segment of disorder covering the
majority of hNek6 N-terminal extension before its cata-
lytic domain, which we are calling here the regulatory
domain. This characteristic is also present in our hNek7
consensus of disorder predictions and in its crystal
structure [28], where amino acids 1-19 are missing resi-
dues (due to a flexible region) and amino acids 20-23
are coils. Notably, we found that hNek6 unfolded short
N-terminal region is important to mediate interactions
with diverse partners [41] and, since hNek6 and hNek7
are similar in their catalytic domain sequences (~86%
identity), but different in their N-terminal extensions
(~20% identity) (Figure 1C), it is possible that both pro-
teins depend on their disordered N-terminal domain to
regulate the interactions with specific/different partners.
For phosphorylation analysis, NetPhosK [42] and Net-
Phos [43] databases were used to predict phosphoryla-
tion sites (Table 1), and together with in vitro and
in vivo p h o s p h o r y l a t i o nd a t a[ 1 3 ] ,t h e yw e r eu s e dt o
assign tyrosine, threonine and serine residues as putative
phosphorylation sites for hNek6 and hNek7 (Figure 1).
This analysis shows a variety of high score phosphoryla-
tion predictions for hNek6. Interestingly, there are four
predicted sites localized in hNek6 N-terminal domain
(serine residues 13, 14, 37 and 41), and one of them
(Ser
37) also described to be phosphorylated in vivo [13],
suggesting that this is an important phosphorylation-
regulated region.
Secondary structure analysis
The secondary structure content of hNek6 was analyzed
by Circular Dichroism (CD) spectroscopy. Figure 2
shows the CD spectra of recombinant wild-type hNek6
f u s e dt oa6 x H i s - t a gr e c o r d e da t4 ° C .P u r i f i e dp r o t e i n
presents negative ellipticity in the far-UV, with minima at
208 (-15567 deg cm
2 dmol
-1) and 222 nm (-12053 deg
cm
2 dmol
-1). This spectrum is typical of many globular
proteins [44] and suggests a high content of a-helices,
since this secondary structure is characterized by minima
around 208 and 222 nm. Deconvolution of the CD spec-
trum using the CDNN software [45] indicated approxi-
mately 41.7% of a-helices, 13.2% of b-strands, 15.7% of
beta-turns and 25.8% of random coils. Deconvolution
using another software, K2d [46], indicated a similar
amount of secondary structure elements: approximately
41% of a-helices, 17% of b-strands and 42% of coils. We
also estimated the quantity of a-helix structure by the
evaluation of the CD spectrum signal at 222 nm, accord-
ing to Corrêa and Ramos, 2009 [47], resulting in 38.6% of
a-helices. Compared to our predictions, wild-type hNek6
showed a very similar content of a-helices (~34%), b-
strands (12%) and coils (54%). In conclusion, both the
in silico prediction and the experimentally derived data
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expected high a-helical content for hNek6.
Comparative molecular modeling of human Nek6
The absence of a three-dimensional structure of hNek6
and the increasing interest in studying Nek proteins within
the context of drug design strategies prompted us to con-
struct a homology model for the aforementioned protein.
Here, we are interested in the activation loop mutant
hNek6(S206A). The activation loop is a centrally located
loop, typically 20-30 residues in length, that provides a
platform for the peptide substrate. Activation of most pro-
tein kinases usually requires phosphorylation of a residue
in this loop, which leads to a rearrangement of the loop
and increase in enzymatic activity [48]. In hNek6, S206 is
an important residue, which phosphorylation leads to an
Figure 1 Human Nek6 and Nek7 structure predictions and sequence aligment. Consensus of predicted secondary structure for Nek6 (A)
and Nek7 (B), is represented by helices (red waves), strands (yellow arrows) and coils (black lines); it was generated from 5 different predictions
and the consensus score for each amino acid (1-5) is shown (scores 1-2 represent ambiguous predictions). The consensus of predicted
disordered regions was generated from 9 predictions; it is represented by blue bars when the consensus score (0-9) is from 5 to 9. The N-
terminal regulatory and C-terminal kinase domains are depicted and two key signatures within the kinase domain are in colored boxes as
follows: ATP-binding region, green; Ser/Thr kinases active-site, orange. The conserved glycine-rich sequence, HRD and DLG motifs are in purple,
and the conserved residues K
74 (b3 strand) and E
93 (aC helix) are in red. The putative nuclear export signal LGDLGL based on la Cour et al., 2004
[63], is underlined and the putative WW domain binding motifs PY and pSP based on Ingham et al., 2005 [64], as well as the PPLP motif
experimentally described for hNek6 by Lee et al., 2007 [65], are indicated by dotted lines. Putative phosphorylation sites were predicted by
NetPhosK 1.0 software and are indicated in blue; S
206 in hNek6 is also indicated because of previously described phosphorylation of this residue
by hNek9 [13]. These motifs are also present in Nek7 amino acid sequence. The author-approved secondary structure of hNek7 in PDB (2WQM)
is also depicted. (C) Primary sequence alignment between human Nek6 (NP_055212.2) and Nek7 (NP_598001.1) using Clustal W2. The N-terminal
regulatory domain is highlighted in yellow.
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activation loop has the capacity to undergo large confor-
mational changes when the kinase switches between inac-
tive and active states, adopting distinct conformations in
different kinases when they are inactive (unphosphorylated
activation loop), a fact that has recently been exploited to
great medical benefit [49] and which makes our hNek6
mutant an interesting target to be studied.
To obtain a homology model of the hNek6 protein, the
crystallographic structure of hNek7, available in the Pro-
tein Data Bank (PDB: 2WQM) [28], was used as a
template. Both proteins share about 77% identity in pri-
mary sequence alignment, being ~86% identical in their
catalytic domain sequences (Figure 1C). Several homol-
ogy/comparative modeling tools were used as described
in the “Methods” section of this article. In order to
choose the best predicted model, stereochemistry quality
analyses were done to check for  and ψ torsion angles
using the Ramachandran plots. A comparison of the
results indicated that the model generated by SWISS-
MODEL [50] is more acceptable than those generated by
the other programs (more amino acids in the most
favourable regions and less in the disallowed regions).
The SWISS-MODEL homology model is shown in
Figure 3. The Ramachandran plot (Additional file 1,
Figure S1A) showed 86.6% residues in the most favour-
able regions, 12.1% in additional allowed regions, 0.8% in
generously allowed regions and 0.4% (only 1 amino acid)
in a disallowed region. As compared to the 2WQM tem-
plate, these values were 90.8%, 8.8%, 0.4% and 0.0%,
respectively. It is important to keep in mind that the tem-
plate has relatively long regions (one of them consists of
18 amino acids) where the phases could not be solved by
X-ray crystallography. Consequently, the homology mod-
eling may not be so accurate in these regions, although
the high identity of the target-template sequences makes
the whole model plausible. The results revealed that the
majority of the amino acids are in a -ψ distribution con-
sistent with right handed a-helix and reliable to be a
good quality model (Additional file 1, Figure S1A). More
details of the validation of the predicted structure results
and its quality assessment using PROSA [51,52] are dis-
played in the Additional Material section (Additional file
1, Figure S1B and S1C). No abnormalities were observed
Table 1 Prediction of putative phosphorylation sites in
human Nek6
Residue
a Putative Upstream Kinase
b Predictor (Score)
S
13 PKA NetPhosK (0.63)
S
14 PKA NetPhosK (0.52)
S
14 Cdc2 NetPhosK (0.53)
S
37 PKC NetPhosK (0.82)
S
41 PKC NetPhosK (0.56)/NetPhos (0.72)
S
41 PKA NetPhosK (0.65)/NetPhos (0.72)
T
70 PKC NetPhosK (0.79)
S
111 CKII NetPhosK (0.64)
S
131 DNAPK NetPhosK (0.62)
S
131 ATM NetPhosK (0.68)
S
158 CKII NetPhosK (0.53)
S
158 Cdc2 NetPhosK (0.51)
T
183 PKC NetPhosK (0.65)
S
198 PKA NetPhosK (0.56)/NetPhos (0.79)
S
198 Cdc2 NetPhosK (0.50)/NetPhos (0.79)
S
199 CKII NetPhosK (0.50)
S
199 Cdc2 NetPhosK (0.55)
T
201 PKC NetPhosK (0.73)
S
206 CKI NetPhosK (0.53)/NetPhos (0.99)
T
210 GSK3 NetPhosK (0.51)
T
210 CDK5 NetPhosK (0.55)
S
215 GSK3 NetPhosK (0.50)/NetPhos (0.99)
S
215 Cdk5 NetPhosK (0.59)/NetPhos (0.99)
Y
224 EGFR NetPhosK (0.55)/NetPhos (0.72)
S
232 PKA NetPhosK (0.67)
S
245 p38MAPK NetPhosK (0.50)
S
245 Cdk5 NetPhosK (0.55)
S
256 CKI NetPhosK (0.54)
S
256 PKC NetPhosK (0.50)
S
275 CKII NetPhosK (0.52)
S
311 PKC NetPhosK (0.66)
a Putative phosphorylated residues predicted with the highest scores by
NetPhosK, which may additionally be predicted by NetPhos server.
b Kinases as predicted by NetPhosK to phosphorylate the corresponded
residue in hNek6 sequence [Protein Kinase A, C or G (PKA, PKC and PKG); Cell
division cycle 2 (Cdc2); Casein Kinase I or II (CKI and CKII); DNA-dependent
Protein Kinase (DNAPK); Ataxia Telangiectasia Mutated (ATM); Ciclin-
dependent kinase 5 (Cdk5); Glycogen synthase kinase 3 (GSK3); Epidermal
Growth Factor Receptor (EGFR); Mitogen-Activated Protein Kinase p38
(p38MAPK)].
Figure 2 Far-UV Circular Dichroism spectra of recombinant
hNek6wt fused to a 6xHis tag. Residual molar ellipticity was
measured from 200 to 260 nm at a protein concentration of 5.8 μM,
in 50 mM Phosphate buffer, pH 7,5 with 300 mM NaCl at 4°C using
a Jasco J-810 spectropolarimeter.
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for the protein.
Our hNek6(S206A) model generated by SWISS-
MODEL [50] shows a short region of a-helix composed
of twelve residues (G
192LGRFFSSETTA
203) following the
conserved DLG motif, with high score (Figure 3). A heli-
cal structure following the DFG/DLG motif is also pre-
sent in hNek2(T175A) structures (PDB: 2JAV, 2W5H
and 2W5B) [26,27] and in other kinase families, such as
inactive forms of both the EGFR kinase [53] and Src/
Hck [54]. Therefore, although the activation loop is
missing in the electron density map of hNek7, a short
helical structure is possibly present in hNek6(S206A),
which was predicted in the model generated by SWISS-
MODEL [50].
Human Nek6 is a monomeric mostly globular, though
slightly elongated protein in solution, as revealed by
SAXS
To study hNek6 molecular structure, in addition to our
homology modeling, we also performed SAXS (Small
Angle X-ray Scattering) experiments for the recombi-
nant 6xHis-hNek6(S206A). SAXS is a very useful
technique for the determination of overall size, shape
and oligomerization status of the macromolecules in
solution [55-58]. Figure 4A shows the corrected and
normalized experimental scattering curve and theoretical
fitting of data by using the program GNOM [59]. The
Guinier region providing an Rg value of 32.0 ± 1.0 Å is
s h o w ni nt h ei n s e t .T h ep(r) function resulting from
these calculations is shown in Figure 4B, with an inset
showing the Kratky representation of the intensity
curve. The Kratky plot indicates a slightly globular con-
formation for 6xHis-hNek6(S206A) in solution,
although, as expected, the same plot also indicated the
presence of flexible regions in the structure, possibly the
N-terminal region and the activation loop. The p(r)
function shows that the protein conformation is slightly
elongated. The maximum dimension (Dmax)v a l u e
obtained was approximately 110 Å and the Rg value cal-
culated from the p(r) function was 32.4 ± 0.8 Å, in close
agreement with that calculated from the Guinier
approximation. Using BSA as a standard sample, the
molecular mass of 6xHis-hNek6(S206A) estimated from
the SAXS data was ~42 kDa. This value indicates that
the protein is a monomer in solution, since the theoreti-
cally calculated molecular mass of the monomer was
~38 kDa (calculated from the amino acid sequence
using ProtParam tool [60]). The molecular mass and
consequently the monomeric nature were also con-
firmed by analytical size-exclusion chromatography
coupled to multi-angle light scattering (SEC-MALS).
The low-resolution models obtained from the SAXS
data by the combination of ab initio calculation and
rigid body modeling methods are presented in Figure 5.
The calculated homology model of the mutant hNek6
(S206A) was used in the rigid body calculation. We dis-
played two typical models of the set of results (Figure
5A and 5B) and a superposition of all 10 models (Figure
5C) obtained in different and independent runs of the
program BUNCH [61]. In spite of the flexibility of the
N-terminal region, the NSD values of the pairwise com-
parison of the models obtained ranged from 0.96 to
1.20, which shows the stability of the independent calcu-
lations. In order to further compare the resulting models
with the information contained in the SAXS curve, we
also calculated one average molecular envelope of the
10 models (Figure 5D) and compared with the filtered
average models obtained from the two sets of 10 purely
ab initio model calculations (Figure 5E and 5F).
Analytical size-exclusion chromatography reveals
variations in human Nek6 conformation dependent on its
phosphorylation status
Analytical Size-Exclusion Chromatography (SEC) was
performed for five variants of recombinant hNek6 fused
to a 6xHis tag: wild-type hNek6 (6xHis-hNek6wt),
Figure 3 Comparative molecular modeling of hNek6(S206A)
based on hNek7 crystal structure. Resulting homology model
obtained using the structure deposited in the protein data bank
under the code 2WQM. The N and C lobes are colored blue and
green, respectively, and the predicted a-helix following the
conserved DLG motif is shown in red. The hinge region and the
activation loop (T-loop) are depicted.
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(S206A), kinase domain of wild-type hNek6 (6xHis-
hNek6(Δ1-44)), and dephosphorylated wild-type and
mutant hNek6 (6xHis-hNek6wtD and 6xHis-hNek6
(S206A)D). Interestingly, the dephosphorylated wild-type
and mutant proteins, which were co-expressed with
lambda phosphatase, were eluted at equal elution
volumes (Figure 6A), showing the same Stokes radius of
~2.1 nm, while the more phosphorylated wild-type
hNek6 showed a larger radius of ~2.6 nm and the par-
tially phosphorylated mutant hNek6(S206A) showed an
intermediate radius of ~2.4 nm (Figure 6B, Table 2). As
expected, 6xHis-hNek6(Δ1 - 4 4 )s h o w e dt h es m a l l e s t
radius of ~1.8 nm. Wild-type hNek6 elution curve also
showed a smaller peak corresponding to a population of
higher molecular weight, possibly due to aggregates. It is
interesting to compare the Stokes radius estimated by
SEC for 6xHis-hNek6(S206A) (~2.4 nm) with the radius
of gyration determined by SAXS (~3.2 nm). The result-
ing ratio Rg/Rs for this protein is ~1.3 and, as Rg/Rs
ratios are reported to vary from 0.78 for homogeneous
spheres, up to values nearing 2 for extended coils and
prolate ellipsoids [62]. This reinforces our results that
hNek6 has a slightly elongated conformation, with a
flexible unfolded N-terminal domain contributing to this
shape.
SEC was also coupled to MALS (Multi-Angle Light
Scattering), which is an useful technique to measure the
weight average molecular masses (Mw) of the eluted
proteins, as described in the Methods section. As
expected, wild-type and mutant hNek6, dephosphory-
lated or not, showed a Mw of ~38 kDa, while the kinase
domain showed a Mw of ~33 kDa (Table 3, Additional
file 1, Figure S2). This corroborates our experimental
data from SAXS for 6xHis-hNek6(S206A) and the theo-
retically calculated molecular masses for all hNek6 var-
iants, showing that hNek6 is a monomer in solution.
These results suggest that, although having the same
molecular mass of ~38 kDa, wild-type hNek6 is purified
from bacteria more phosphorylated than its mutant var-
iant, mainly because of their different activation/autop-
hosphorylation status, as described by Meirelles et al.
[41], and these different phosphorylation degrees may
cause changes in protein conformation and compact-
ness, resulting in changes in their Stokes radii. This was
better visualized for both proteins when dephosphory-
lated by lambda phosphatase, which promoted smaller
radii and, possibly, more compact or less hydrated con-
formations. It seems that an increase in phosphorylation
induces a structural change that increases the apparent
size or shape of hNek6. In fact, in most kinases, the
activation loop is phosphorylated when the kinase is
active, which stabilizes it in an open and extended con-
formation that is permissive for substrate binding [49].
This phosphorylated extended conformation may there-
fore contribute to the increase in hNek6 Stokes radius.
All hNek6 variants were submitted to SEC-MALS twice,
using two different buffers (the same one used for SAXS
and another one containing 600 mM NaCl in order to
avoid any unspecific binding to the gel filtration column
resin), and the same Stokes radii for each protein were
obtained in both measurements. Figure 6 shows the
results from SEC-MALS using the buffer containing
600 mM NaCl, and Tables 2 and 3 show all the results
obtained from both measurements.
Thermal denaturation shift assays were also performed
for the five recombinant hNek6 variants described
above. The results revealed a slightly higher stability of
Figure 4 Small Angle X-Ray Scattering (SAXS) of recombinant hNek6(S206A). (A) Experimental SAXS curve from hNek6(S206A) (open
circles) and the theoretical fitting (solid line) calculated using the program GNOM. Inset: Guinier region and linear fit. (B) Pair distance
distribution function p(r). Inset: Kratky plot (q
2I(q) vs. q) of the intensity curve.
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Page 6 of 13Figure 5 Low-resolution models of hNek6(S206A) obtained from the SAXS data using a combination of ab initio calculations and rigid
body modeling. (A and B) Two typical models selected from the set of 10 resulting models. (C) Superposition of all 10 models obtained in
different and independent runs of the program BUNCH. (D) Three orthogonal views of the average molecular envelope of the 10 low resolution
BUNCH models. (E) Three orthogonal views of the ab initio dummy atoms model. (F) Three orthogonal views of the ab initio dummy residues
model.
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mutant (Figure 7, Table 3). This may be explained by
the fact that, in many kinases, like PKA, phosphorylation
of the activation loop cause global stabilization of the
active site [63], and molecular dynamics simulation of
Cdk2 has demonstrated a decrease of B-factors through-
out the molecule upon phosphorylation [64]. A model
was proposed that dephosphorylation of the activation
loop leads to mutual repulsion of the positive charges
that were bound to the phosphate, which leads to the
destabilization of the magnesium-binding loop, move-
ment of the aC-helix out of the active site, disturbance
of the hydrophobic spine, and loosening of the N-lobe,
thereby providing an explanation of the protein kinase
stabilization induced by phosphorylation [48]. This may
therefore also reflect a higher stability for the wild-type
hNek6 compared to its activation loop mutant in ther-
mal melting measurements.
Conclusions
Our data presents the first low resolution 3D structure of
hNek6 protein in solution. SAXS experiments show that
hNek6 is a monomer of a mostly globular, though slightly
elongated shape, which was also confirmed by analytical
SEC-MALS experiments. These also showed that hNek6
conformation is dependent on its activation/phosphoryla-
tion status, a higher phosphorylation degree corresponding
to a bigger Stokes radius. Thermal denaturation shift assays
revealed a slightly higher stability of wild-type hNek6 com-
pared to the activation loop mutant hNek6(S206A).
Methods
In silico sequence analysis
Human Nek6 and Nek7 amino acid sequences were used
as queries in five different secondary structure prediction
databases: PredictProtein/Prof [29], PSIPRED [30], SSpro
[31], SOPMA [32] and GOR4 [33]. Comparison of their
outputs resulted in a consensus of predicted secondary
Figure 6 Analytical size-exclusion chromatography of recombinant hNek6 variants fused to a 6xHis tag. (A) Chromatographic profile of hNek6
variants (colored lines) and a mixture of standard proteins (dashed line). (B) Linear fit of known Stokes radii (Rs) as a function of the measured partition
coefficient (Kav). The colored circles show the partition coefficient of hNek6 variants, and the black squares, the partition coefficients of the standards.
The circles colors correspond to the same colors depicted in (A). The proteins were eluted in 50 mM HEPES pH 7.5, 5 mM sodium phosphate, 600 mM
NaCl, 5% glycerol, as homogeneous species at different elution volumes (Ve) using an analytical Superdex 200 10/300 GL column. Conalbumin,
ovalbumin, carbonic anhydrase and ribonuclease were used as Stokes radii standards. (wt: wild-type, D: dephosphorylated).
Table 2 Recombinant hNek6 Stokes radii (Rs) determined
by analytical size-exclusion chromatography
Protein Rs (nm) Ve (mL)
a Apparent Rs (nm)
a
Conalbumin 3.6 14.9 ± 0.1 3.5 ± 0.2
Ovalbumin 3.0 15.8 ± 0.1 2.9 ± 0.0
Carbonic Anhydrase 2.0 16.9 ± 0.1 2.2 ± 0.0
Ribonuclease 1.6 18.2 ± 0.0 1.4 ± 0.1
Nek6wt 16.4 ± 0.3 2.6 ± 0.1
Nek6wtD 17.1 ± 0.0 2.1 ± 0.0
Nek6(S206A) 16.7 ± 0.2 2.4 ± 0.0
Nek6(S206A)D 17.1 ± 0.0 2.1 ± 0.0
Nek6(Δ1-44) 17.6 ± 0.3 1.8 ± 0.1
a S.E. of two measurements at different buffers.
Table 3 Recombinant hNek6 weight average molecular
masses (Mw) determined by SEC-MALS and melting
temperatures (Tm) during thermal shift denaturation
Protein Pred. M (kDa)
a Mw (kDa)
b Apparent Tm (°C)
c
Nek6wt 37.7 38.4 ± 0.6 39.5 ± 0.1
Nek6wtD 37.7 37.8 ± 2.2 40.8 ± 0.1
Nek6(S206A) 37.7 38.1 ± 2.1 38.0 ± 0.1
Nek6(S206A)D 37.7 38.4 ± 3.3 36.8 ± 0.3
Nek6(Δ1-44) 33.2 33.3 ± 1.6 41.0 ± 0.2
a Molecular masses predicted by ProtParam tool [60].
b S.E. of two measurements at different buffers.
c S.E. of three measurements.
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Page 8 of 13structure, where each amino acid was assigned a score
ranging from 1 to 5. Our Nek7 consensus of predicted
secondary structure was compared to the author-
approved secondary structure in PDB (2WQM) as a
measure to validate our analysis. We also performed dis-
ordered regions analysis for both protein sequences using
nine different predictors: FoldIndex [34], GlobPlot Rus-
sell/Linding [35], PONDR VL-XT [36], DISpro [37],
IUPred [38], DisEMBL Hot-loops, DisEMBL Remark-
465, DisEMBL Loops/coils [39], and VSL2B [40]. From
this, a consensus of predicted disordered regions was
generated with a consensus score ranging from 0 to 9,
where a score above 4 represents disorder. Additionally,
NetPhosK [42] and NetPhos [43] databases were used to
predict phosphorylation sites for human Nek6 and Nek7.
The conserved glycine-rich sequence, the HRD and DLG
motifs, the conserved residues K
74 (b3 strand) and E
93
(aC helix), the putative nuclear export signal LGDLGL
based on la Cour et al., 2004 [65], the putative WW
domain binding motifs PY and pSP based on Ingham
et al., 2005 [66], as long as the PPLP motif, experimen-
tally described for hNek6 by Lee et al., 2007 [67], were
also assigned to both protein sequences.
Plasmid Constructions
All plasmid constructions were developed accordingly to
Meirelles et al., 2010 [41].
Site-directed Mutagenesis
The hNek6 activation loop mutation S206A was intro-
duced by PCR-based mutagenesis accordingly to Meir-
elles et al., 2010 [41].
Protein Expression and Purification
Soluble full-length hNek6 wild-type - 6xHis-hNek6wt -
and mutant - 6xHis-hNek6(S206A) - or truncated
hNek6 wild-type kinase domain - 6xHis-hNek6(Δ1-44) -
fused to a 6xHis tag were expressed and purified
accordingly to Meirelles et al., 2010 [41].
Protein Dephosphorylation
In order to obtain dephosphorylated wild-type and
mutant hNek6, plasmids encoding either 6xHis-
hNek6wt or 6xHis-hNek6(S206A) and l phosphatase
were transformed into E. coli BL21 (DE3/pRARE) cells
that were induced and purified as described by Meirelles
et al., 2010 [41]. Lambda phosphatase cloned into
pCDF-Duet (Novagen) was kindly provided by Dr.
Richard Bayliss (Section of Structural Biology, Institute
of Cancer Research, London, UK).
Circular dichroism
Circular dichroism (CD) spectra were recorded in a
JASCO model J-810 CD spectropolarimeter equipped
with Peltier-type system PFD 425S. Data were collected
from 260 to 200 nm at 4°C using a quartz cuvette of 1
mm pathlength. Thirty-two spectra of purified 6xHis-
hNek6wt at 5.8 μM, in 50 mM Phosphate buffer pH 7.5,
300 mM NaCl, were averaged and corrected from the
baseline for buffer solvent contribution. Experimental
data were analyzed using CDNN [45] and K2d [46]
softwares.
Comparative/Homology Molecular Modeling
The comparative/homology molecular modeling and
model validation were performed in a similar way to
that described in Bodade et al., 2010 [68]. Briefly, sev-
eral comparative/homology modeling tools were used:
I-TASSER [69-71], Geno3D [72], 3D-JIGSAW [73-75],
SWISS-MODEL [50] and MODELLER 9v8 [76]. The
NCBI Basic Local Alignment Search Tool (BLAST,
http://www.ncbi.nlm.nih.gov/BLAST/) was used to
search the crystal structure of the closest homologue
available in the Protein Data Bank (PDB, http://www.
rcsb.org/pdb/). The input was the amino acid sequence
of hNek6(S206A). The NCBI results revealed that the
structure of hNek7, deposited under the code 2WQM
i nt h eP D B ,w a sav e r ys u i t a b l et e m p l a t e( i d e n t i t y
score of 81% and E-value 3 × 10
-141). This structure
was used as a single template for the modeling
approach. The overall stereochemical quality of the
models was assessed by PROCHECK software [77].
The quality of the models was also evaluated by
PROSA [51,52] and by the standard validation proce-
dures included in the automated mode of the SWISS-
MODEL server [50].
Figure 7 Thermal shift denaturation of recombinant hNek6
variants fused to a 6xHis tag. The graph shows representative
thermal shift data (markers) and fitted curves (lines). Proteins were
buffered in 10 mM HEPES pH 7.5, 150 mM NaCl and assayed at a
final concentration of 2.0 μMi n2 5μL volume. SYPRO-Orange
(Molecular Probes) was added as a fluorescence probe at a dilution
of 1 in 1000. Temperature was raised with a step of 1°C per 1.0 min
from 10°C to 85°C and fluorescence readings were taken at each
interval. (wt: wild-type, D: dephosphorylated).
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The sample was first inspected by dynamic light scatter-
ing (DLS) to test for its monodispersity and then ultra-
centrifuged at 200.000 × g for 40 min at 4°C to remove
any possible aggregates. The SAXS experiments were
performed at the D02A-SAXS2 beam line at the LNLS,
and data treatment and analyses were done following
standard procedures similar to those described in Trin-
dade et al., 2009 [57]. Briefly, the measurements were
performed at 4°C and the sample-to-detector distance
was 902 mm, covering a scattering vector range of
0.015Å
-1 < q <0.25 Å
-1 (q is the magnitude of the q-vec-
tor defined by q = (4π/l)sinθ and 2θ is the scattering
angle) using a wavelength of l = 1.488 Å. The measure-
ments were performed using two different protein con-
centrations in HEPES buffer (50 mM HEPES pH 7.5,
5 mM sodium phosphate, 300 mM NaCl, 5% glycerol,
200 mM imidazole): 0.5 and 1.0 mg/mL. A 8 mg/ml
B S A( 6 6k D a )s o l u t i o ni nt h es a m es a m p l eb u f f e rw a s
used as a standard sample to estimate the molecular
mass of 6xHis-hNek6(S206A) making use of the ratio of
the extrapolated values of the intensity at the origin, I(0)
[78,79]. The radius of gyration (Rg) was calculated from
the Guinier approximation (valid for qRg < 1.3) [80-82]
and also from the pair distance distribution function,
p(r), which was obtained using the program GNOM
[56]. The maximum dimension (Dmax) of the molecule
was obtained from the p(r) function. The Kratky plot
(q
2I(q)v s .q) [81,82] was used to analyze the compact-
ness of the protein conformation.
Low resolution SAXS-based modeling
The low resolution model of 6xHis-hNek6(S206A) was
obtained from the SAXS data using a combination of
ab initio calculation and rigid body modeling methods.
Taking advantage of the homology model obtained, we
used the program BUNCH [61] to model the protein.
No symmetry restraints were used in the calculation.
We would like to mention that no unique solution can
be obtained from these calculations. For this reason, 10
independent calculations were run for each sample data.
The multiple solutions were analyzed and the reliability
and stability of the set of models were estimated. A pair-
wise comparison and the normalized spatial discrepancy
(NSD) evaluation was performed using the DAMAVER
program suite [83] complemented by the SUPCOMB
[84] routine. Analyzing the NSD values (which describe
the dissimilarity between pairs of models of the several
calculations), the models with common features led to
the selection of a representative, low resolution confor-
mation for hNek6(S206A) protein. Models were dis-
played by the PyMOL program [85].
For comparison purposes, two other low resolution
models were also obtained by using two different
ab initio approaches: the dummy atoms method imple-
mented in the program DAMMIN [86] and the dummy
residues method implemented in GASBOR [87]. The
procedures were similar to those described in Trindade
et al. [57].
SEC-MALS Analysis
We used Analytical Size-Exclusion Chromatography
coupled to Multi-Angle Light Scattering (SEC-MALS) to
estimate the hydrodynamic or Stokes radii (Rs)o f
recombinant hNek6wt, hNek6(S206A), hNek6(Δ1-44)
and dephosphorylated hNek6wt and hNek6(S206A), all
fused to a 6xHis tag. SEC was performed with an analy-
tical Superdex 200 10/300 GL column using an ÄKTA
FPLC system (GE Healthcare) equilibrated with two col-
umn volumes of 50 mM HEPES pH 7.5, 5 mM sodium
phosphate, 600 mM NaCl, 5% glycerol, at a flow rate of
0.5 ml/min, at 20°C. Recombinant hNek6 variants at
concentrations ranging from 0.2 to 0.7 mg/ml and a
mixture of standard proteins with known Stokes radii
(conalbumin: 3.64 nm, 3.2 mg/ml; ovalbumin: 3.05 nm,
4.2 mg/ml; carbonic anhydrase: 2.30 nm, 3.0 mg/ml; and
ribonuclease: 1.64 nm, 3.4 mg/ml) (Sigma) were loaded
onto the column and their elution profiles were moni-
tored by absorbance at 280 nm. The Stokes radius of
each hNek6 variant was estimated by a linear fit of the
Stokes radii of the standard proteins versus the partition
coefficient Kav [88,89] as described by the equation: Kav
= Ve - Vo/Vt - Vo ,w h e r eVe is the elution volume of
the protein, Vo the void volume and Vt is the total
volume of the column. The SEC was also coupled to a
DAWN TREOS™ MALS instrument (Wyatt Technol-
ogy). The on-line measurement of the intensity of the
Rayleigh scattering as a function of the angle of the elut-
ing peaks in SEC was used to determine the weight
average molecular masses (Mw)o ft h ee l u t e dp r o t e i n s
[90], using the ASTRA™ (Wyatt Technologies) soft-
ware. SEC-MALS measurements were performed using
two different buffers: the first one described above for
SEC and a second one also used in SAXS experiments
(50 mM HEPES pH 7.5, 5 mM sodium phosphate,
300 mM NaCl, 5% glycerol, 200 mM imidazole). The
chromatographic profile of the recombinant hNek6 var-
iants were the same in both measurements and the mean
and standard errors of their Mw and Mn were calculated.
Thermal Shift Assays
Thermal shift assays were performed based on a proto-
col devised by the Structural Genomics Consortium [91]
using a real time PCR machine 7300 (Applied Biosys-
tems). Proteins were buffered in 10 mM HEPES pH 7.5,
150 mM NaCl and assayed at a final concentration of
2.0 μMi n2 5μL volume. SYPRO-Orange (Molecular
Probes) was added as a fluorescence probe at a dilution
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Page 10 of 13of 1 in 1000. The emission filter for the SYPRO-Orange
dye was set to 580 nm. Temperature was raised with a
step of 1°C per 1.0 min from 10°C to 85°C and fluores-
cence readings were taken at each interval. OriginPro 8
software was used to fit data to the Boltzmann equation,
y = LL+(UL-LL)/1+exp((Tm-x)/a), where LL and UL are
the slopes of the native and denatured baselines, Tm is
the apparent melting temperature and a describes the
slope of the denaturation. Tm values were calculated by
determination of the maximum of the first derivative.
Additional material
Additional file 1: Supplemental Figures S1 and S2, PROCHECK and
PROSA analysis results of the validation procedures of the hNek6
(S206A) homology/comparative model and Analytical SEC-MALS of
the five recombinant protein variants of Nek6. Figure S1: PROCHECK
and PROSA analysis results of the validation procedures of the hNek6
(S206A) homology/comparative model. (A) Ramachandran Plot calculated
using the program PROCHECK. (B) Plot of the residue score showing the
local model quality by plotting energies as a function of the residue
sequence position using PROSA. In general, positive values correspond to
problematic or erroneous parts of the structure. Here, the plots were
smoothed by calculation the average energy over 10- and 40-residues.
This average is needed because of the large fluctuation in a plot of
single residue energies. (C) The Z-score indicated overall model quality
using PROSA. The Z-score of the hNek6(S206A) model was -7.14 (black
point). The plot contains the Z-scores of all experimentally determined
protein chains in the current PDB. The structure determined by X-ray and
NMR are distinguished by different colors. Figure S2: Analytical SEC-MALS
of recombinant (A) hNek6wt, (B) hNek6wtD, (C) hNek6(S206A), (D) hNek6
(S206A)D and (E) hNek6(Δ1-44). The Mw determined by MALS
correspond to a monomer in all five cases.
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